The energy giant is buying
The drugstore operator named
The electrical equipment maker beat analysts' fiscal second-quarter earnings and revenue forecasts.
The consumer electronics maker reported strong fiscal second-quarter revenue.
The drug developer gave investors an encouraging update on a study using the weight-loss drug Ozempic to treat kidney failure.
The kidney dialysis provider slumped amid worries about competition from a potential kidney-failure drug from
The alternative energy company gave investors an encouraging business and operations update.
The health insurer said
Copyright 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
, source